Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults

Adriana Weinberg, Jennifer Canniff, Nadine Rouphael, Aneesh Mehta, Mark Mulligan, Jennifer A. Whitaker, Myron J. Levin

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The incidence and severity of herpes zoster (HZ) increases with age. The live attenuated zoster vaccine generates immune responses similar to HZ.We compared the immune responses to zoster vaccine in young and older to adults to increase our understanding of the immune characteristics that may contribute to the increased susceptibility to HZ in older adults. Young (25-40 y; n = 25) and older (60-80 y; n = 33) adults had similar magnitude memory responses to varicella-zoster virus (VZV) ex vivo restimulation measured by responder cell-frequency and flow cytometry, but the responses were delayed in older compared with young adults. Only young adults had an increase in dual-function VZV-specific CD4+ and CD8+ T cell effectors defined by coexpression of IFNg, IL-2, and CD107a after vaccination. In contrast, older adults showed marginal increases in VZV-specific CD8+CD57+ senescent T cells after vaccination, which were already higher than those of young adults before vaccination. An increase in VZV-stimulated CD4+CD69+CD57+PD1+ and CD8+CD69+CD57+PD1+ T cells from baseline to postvaccination was associated with concurrent decreased VZV-memory and CD8+ effector responses, respectively, in older adults. Blocking the PD1 pathway during ex vivo VZV restimulation increased the CD4+ and CD8+ proliferation, but not the effector cytokine production, which modestly increased with TIM-3 blockade.We conclude that high proportions of senescent and exhausted VZV-specific T cells in the older adults contribute to their poor effector responses to a VZV challenge. This may underlie their inability to contain VZV reactivation and prevent the development of HZ.

Original languageEnglish (US)
Pages (from-to)604-612
Number of pages9
JournalJournal of Immunology
Volume199
Issue number2
DOIs
StatePublished - Jul 15 2017
Externally publishedYes

Fingerprint

Herpes Zoster Vaccine
Attenuated Vaccines
Human Herpesvirus 3
Cellular Immunity
Young Adult
Herpes Zoster
T-Lymphocytes
Vaccination
Interleukin-2
Flow Cytometry

ASJC Scopus subject areas

  • Immunology

Cite this

Weinberg, A., Canniff, J., Rouphael, N., Mehta, A., Mulligan, M., Whitaker, J. A., & Levin, M. J. (2017). Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. Journal of Immunology, 199(2), 604-612. https://doi.org/10.4049/jimmunol.1700290

Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. / Weinberg, Adriana; Canniff, Jennifer; Rouphael, Nadine; Mehta, Aneesh; Mulligan, Mark; Whitaker, Jennifer A.; Levin, Myron J.

In: Journal of Immunology, Vol. 199, No. 2, 15.07.2017, p. 604-612.

Research output: Contribution to journalArticle

Weinberg, A, Canniff, J, Rouphael, N, Mehta, A, Mulligan, M, Whitaker, JA & Levin, MJ 2017, 'Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults', Journal of Immunology, vol. 199, no. 2, pp. 604-612. https://doi.org/10.4049/jimmunol.1700290
Weinberg, Adriana ; Canniff, Jennifer ; Rouphael, Nadine ; Mehta, Aneesh ; Mulligan, Mark ; Whitaker, Jennifer A. ; Levin, Myron J. / Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. In: Journal of Immunology. 2017 ; Vol. 199, No. 2. pp. 604-612.
@article{81948ac82b31439a8b2c2dfe5c910cbd,
title = "Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults",
abstract = "The incidence and severity of herpes zoster (HZ) increases with age. The live attenuated zoster vaccine generates immune responses similar to HZ.We compared the immune responses to zoster vaccine in young and older to adults to increase our understanding of the immune characteristics that may contribute to the increased susceptibility to HZ in older adults. Young (25-40 y; n = 25) and older (60-80 y; n = 33) adults had similar magnitude memory responses to varicella-zoster virus (VZV) ex vivo restimulation measured by responder cell-frequency and flow cytometry, but the responses were delayed in older compared with young adults. Only young adults had an increase in dual-function VZV-specific CD4+ and CD8+ T cell effectors defined by coexpression of IFNg, IL-2, and CD107a after vaccination. In contrast, older adults showed marginal increases in VZV-specific CD8+CD57+ senescent T cells after vaccination, which were already higher than those of young adults before vaccination. An increase in VZV-stimulated CD4+CD69+CD57+PD1+ and CD8+CD69+CD57+PD1+ T cells from baseline to postvaccination was associated with concurrent decreased VZV-memory and CD8+ effector responses, respectively, in older adults. Blocking the PD1 pathway during ex vivo VZV restimulation increased the CD4+ and CD8+ proliferation, but not the effector cytokine production, which modestly increased with TIM-3 blockade.We conclude that high proportions of senescent and exhausted VZV-specific T cells in the older adults contribute to their poor effector responses to a VZV challenge. This may underlie their inability to contain VZV reactivation and prevent the development of HZ.",
author = "Adriana Weinberg and Jennifer Canniff and Nadine Rouphael and Aneesh Mehta and Mark Mulligan and Whitaker, {Jennifer A.} and Levin, {Myron J.}",
year = "2017",
month = "7",
day = "15",
doi = "10.4049/jimmunol.1700290",
language = "English (US)",
volume = "199",
pages = "604--612",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Varicella-zoster virus-specific cellular immune responses to the live attenuated zoster vaccine in young and older adults

AU - Weinberg, Adriana

AU - Canniff, Jennifer

AU - Rouphael, Nadine

AU - Mehta, Aneesh

AU - Mulligan, Mark

AU - Whitaker, Jennifer A.

AU - Levin, Myron J.

PY - 2017/7/15

Y1 - 2017/7/15

N2 - The incidence and severity of herpes zoster (HZ) increases with age. The live attenuated zoster vaccine generates immune responses similar to HZ.We compared the immune responses to zoster vaccine in young and older to adults to increase our understanding of the immune characteristics that may contribute to the increased susceptibility to HZ in older adults. Young (25-40 y; n = 25) and older (60-80 y; n = 33) adults had similar magnitude memory responses to varicella-zoster virus (VZV) ex vivo restimulation measured by responder cell-frequency and flow cytometry, but the responses were delayed in older compared with young adults. Only young adults had an increase in dual-function VZV-specific CD4+ and CD8+ T cell effectors defined by coexpression of IFNg, IL-2, and CD107a after vaccination. In contrast, older adults showed marginal increases in VZV-specific CD8+CD57+ senescent T cells after vaccination, which were already higher than those of young adults before vaccination. An increase in VZV-stimulated CD4+CD69+CD57+PD1+ and CD8+CD69+CD57+PD1+ T cells from baseline to postvaccination was associated with concurrent decreased VZV-memory and CD8+ effector responses, respectively, in older adults. Blocking the PD1 pathway during ex vivo VZV restimulation increased the CD4+ and CD8+ proliferation, but not the effector cytokine production, which modestly increased with TIM-3 blockade.We conclude that high proportions of senescent and exhausted VZV-specific T cells in the older adults contribute to their poor effector responses to a VZV challenge. This may underlie their inability to contain VZV reactivation and prevent the development of HZ.

AB - The incidence and severity of herpes zoster (HZ) increases with age. The live attenuated zoster vaccine generates immune responses similar to HZ.We compared the immune responses to zoster vaccine in young and older to adults to increase our understanding of the immune characteristics that may contribute to the increased susceptibility to HZ in older adults. Young (25-40 y; n = 25) and older (60-80 y; n = 33) adults had similar magnitude memory responses to varicella-zoster virus (VZV) ex vivo restimulation measured by responder cell-frequency and flow cytometry, but the responses were delayed in older compared with young adults. Only young adults had an increase in dual-function VZV-specific CD4+ and CD8+ T cell effectors defined by coexpression of IFNg, IL-2, and CD107a after vaccination. In contrast, older adults showed marginal increases in VZV-specific CD8+CD57+ senescent T cells after vaccination, which were already higher than those of young adults before vaccination. An increase in VZV-stimulated CD4+CD69+CD57+PD1+ and CD8+CD69+CD57+PD1+ T cells from baseline to postvaccination was associated with concurrent decreased VZV-memory and CD8+ effector responses, respectively, in older adults. Blocking the PD1 pathway during ex vivo VZV restimulation increased the CD4+ and CD8+ proliferation, but not the effector cytokine production, which modestly increased with TIM-3 blockade.We conclude that high proportions of senescent and exhausted VZV-specific T cells in the older adults contribute to their poor effector responses to a VZV challenge. This may underlie their inability to contain VZV reactivation and prevent the development of HZ.

UR - http://www.scopus.com/inward/record.url?scp=85023169153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023169153&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1700290

DO - 10.4049/jimmunol.1700290

M3 - Article

C2 - 28607114

AN - SCOPUS:85023169153

VL - 199

SP - 604

EP - 612

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -